The expression of P protein from every plasmid construct was verified by SDS–polyacrylamide gel electrophoresis (PAGE) and Western blot. 293T or BSR-T7 cells were plated in a 12-well plate at 2 × 105 cells per well in DMEM supplemented with 10% of FBS. The next day, cells were transfected with 2 μg of plasmid with jetPRIME (Polyplus). For the assessment of L stability, some cells were also treated 6 hours after transfection with 2 μM 17-DMAG. Twenty-four hours after transfection, cells were trypsinized, washed with phosphate-buffered saline (PBS), and lysed for 30 min on ice. Cells expressing P only were lysed with a urea-free lysis buffer [50 mM tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, 5% glycerol, 1 mM dithiothreitol, and cOmplete protease inhibitor (Roche)], and cells expressing L were lysed with the same buffer supplemented with 8 M urea. Proteins were separated by SDS-PAGE and electrotransferred onto polyvinylidene difluoride membranes (Hybond-P, Amersham Biosciences). After saturation for 1 hour in tris-buffered saline (TBS) containing 0.05% Tween 20 (TBS-Tween) and 5% fat-free milk, the membranes were incubated for 2 hours with primary antibodies specific for P [either the mouse monoclonal antibody 49.21 (56) or a rabbit polyclonal antibody (37, 56) diluted 1:3000 and 1:10,000 in TBS–Tween–5% milk, respectively] or Flag/L (1:2000; mouse anti-Flag monoclonal antibody, Sigma), washed with TBS-Tween, and incubated with peroxidase-conjugated sheep anti-mouse or anti-rabbit immunoglobulin G (IgG) antibody (Promega) for 1 hour at room temperature. The membranes were then washed and incubated in Covalight reagent (Covalab), and chemiluminescent signals were measured with the VersaDoc Imaging System (Bio-Rad). All P variants migrated at their expected molecular weight. Expression levels of the P MD variants that were tested in the minigenome assay were assessed using a semiquantitative dot blot assay as described previously (73) using the two anti-P antibodies described above.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。